ID   QUEF_ECOLI              Reviewed;         282 AA.
AC   Q46920; Q2MA40;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-FEB-2017, entry version 128.
DE   RecName: Full=NADPH-dependent 7-cyano-7-deazaguanine reductase;
DE            EC=1.7.1.13;
DE   AltName: Full=7-cyano-7-carbaguanine reductase;
DE   AltName: Full=NADPH-dependent nitrile oxidoreductase;
DE   AltName: Full=PreQ(0) reductase;
GN   Name=queF; Synonyms=yqcD; OrderedLocusNames=b2794, JW2765;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [3]
RP   FUNCTION, KINETIC PARAMETERS, AND SUBUNIT.
RX   PubMed=15767583; DOI=10.1073/pnas.0408056102;
RA   Van Lanen S.G., Reader J.S., Swairjo M.A., de Crecy-Lagard V., Lee B.,
RA   Iwata-Reuyl D.;
RT   "From cyclohydrolase to oxidoreductase: discovery of nitrile reductase
RT   activity in a common fold.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:4264-4269(2005).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, KINETIC
RP   PARAMETERS, 3D-STRUCTURE MODELING, ACTIVE SITES, AND MUTAGENESIS OF
RP   GLU-89; SER-90; CYS-190; ASP-197; PHE-228; HIS-229 AND GLU-230.
RC   STRAIN=K12;
RX   PubMed=23595998; DOI=10.1002/chem.201300163;
RA   Wilding B., Winkler M., Petschacher B., Kratzer R., Egger S.,
RA   Steinkellner G., Lyskowski A., Nidetzky B., Gruber K., Klempier N.;
RT   "Targeting the substrate binding site of E. coli nitrile reductase
RT   QueF by modeling, substrate and enzyme engineering.";
RL   Chemistry 19:7007-7012(2013).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND 3D-STRUCTURE MODELING.
RC   STRAIN=K12;
RX   PubMed=23410922; DOI=10.1016/j.enzmictec.2012.12.003;
RA   Moeller K., Nguyen G.S., Hollmann F., Hanefeld U.;
RT   "Expression and characterization of the nitrile reductase queF from E.
RT   coli.";
RL   Enzyme Microb. Technol. 52:129-133(2013).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of 7-cyano-7-
CC       deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine (preQ1), a
CC       late step in the queuosine pathway. Is highly specific for its
CC       natural substrate preQ0, since it cannot use various aliphatic,
CC       aromatic, benzylic and heterocyclic nitriles, such as
CC       acetonitrile, benzonitrile, benzylcyanide and 2-cyanopyrrole,
CC       although it can reduce the substrate analog 5-cyanopyrrolo[2,3-
CC       d]pyrimidin-4-one with lesser efficiency.
CC       {ECO:0000269|PubMed:15767583, ECO:0000269|PubMed:23410922,
CC       ECO:0000269|PubMed:23595998}.
CC   -!- CATALYTIC ACTIVITY: 7-aminomethyl-7-carbaguanine + 2 NADP(+) = 7-
CC       cyano-7-carbaguanine + 2 NADPH. {ECO:0000269|PubMed:23410922,
CC       ECO:0000269|PubMed:23595998}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=36 uM for NADPH {ECO:0000269|PubMed:15767583,
CC         ECO:0000269|PubMed:23410922, ECO:0000269|PubMed:23595998};
CC         KM=6.0 uM for NADPH {ECO:0000269|PubMed:15767583,
CC         ECO:0000269|PubMed:23410922, ECO:0000269|PubMed:23595998};
CC         KM=6.1 uM for 7-cyano-7-deazaguanine
CC         {ECO:0000269|PubMed:15767583, ECO:0000269|PubMed:23410922,
CC         ECO:0000269|PubMed:23595998};
CC         KM=176 uM for 5-cyanopyrrolo[2,3-d]pyrimidin-4-one
CC         {ECO:0000269|PubMed:15767583, ECO:0000269|PubMed:23410922,
CC         ECO:0000269|PubMed:23595998};
CC         Note=KM for preQ0 appears to be inferior to 1.5 uM, and kcat is
CC         0.1268 sec(-1) (PubMed:23410922). kcat is 6.5 min(-1) with preQ0
CC         as substrate and 3.6 min(-1) with 5-cyanopyrrolo[2,3-
CC         d]pyrimidin-4-one as substrate (PubMed:23595998).
CC         {ECO:0000269|PubMed:23410922, ECO:0000269|PubMed:23595998};
CC       pH dependence:
CC         Optimum pH is 7. Retains less than 20% of activity at pH 9
CC         (PubMed:23410922). {ECO:0000269|PubMed:23410922};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius. Displays a half life
CC         of 28.2 hours and 12.8 hours at 37 and 40 degrees Celsius,
CC         respectively, but at 50 degrees Celsius the half life time drops
CC         to 6 minutes (PubMed:23410922). {ECO:0000269|PubMed:23410922};
CC   -!- PATHWAY: tRNA modification; tRNA-queuosine biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15767583}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the GTP cyclohydrolase I family. QueF type
CC       2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U29581; AAB40444.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75836.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76866.1; -; Genomic_DNA.
DR   PIR; F65061; F65061.
DR   RefSeq; NP_417274.1; NC_000913.3.
DR   RefSeq; WP_000100421.1; NZ_LN832404.1.
DR   ProteinModelPortal; Q46920; -.
DR   SMR; Q46920; -.
DR   BioGrid; 4262149; 54.
DR   DIP; DIP-12848N; -.
DR   IntAct; Q46920; 6.
DR   MINT; MINT-1288325; -.
DR   STRING; 511145.b2794; -.
DR   PaxDb; Q46920; -.
DR   PRIDE; Q46920; -.
DR   EnsemblBacteria; AAC75836; AAC75836; b2794.
DR   EnsemblBacteria; BAE76866; BAE76866; BAE76866.
DR   GeneID; 947270; -.
DR   KEGG; ecj:JW2765; -.
DR   KEGG; eco:b2794; -.
DR   PATRIC; 32121004; VBIEscCol129921_2894.
DR   EchoBASE; EB2965; -.
DR   EcoGene; EG13173; queF.
DR   eggNOG; ENOG4107R1K; Bacteria.
DR   eggNOG; COG0780; LUCA.
DR   eggNOG; COG2904; LUCA.
DR   HOGENOM; HOG000273755; -.
DR   InParanoid; Q46920; -.
DR   KO; K06879; -.
DR   OMA; QCVERIY; -.
DR   BioCyc; EcoCyc:G7452-MONOMER; -.
DR   BioCyc; MetaCyc:G7452-MONOMER; -.
DR   BRENDA; 1.7.1.13; 2026.
DR   UniPathway; UPA00392; -.
DR   PRO; PR:Q46920; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0046857; F:oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor; IEA:InterPro.
DR   GO; GO:0033739; F:preQ1 synthase activity; IDA:EcoCyc.
DR   GO; GO:0008616; P:queuosine biosynthetic process; IMP:EcoCyc.
DR   HAMAP; MF_00817; QueF_type2; 1.
DR   InterPro; IPR029500; QueF.
DR   InterPro; IPR029139; QueF_N.
DR   InterPro; IPR016428; QueF_type2.
DR   Pfam; PF14489; QueF; 1.
DR   Pfam; PF14819; QueF_N; 1.
DR   PIRSF; PIRSF004750; Nitrile_oxidored_YqcD_prd; 1.
DR   TIGRFAMs; TIGR03138; QueF; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; NADP; Oxidoreductase;
KW   Queuosine biosynthesis; Reference proteome.
FT   CHAIN         1    282       NADPH-dependent 7-cyano-7-deazaguanine
FT                                reductase.
FT                                /FTId=PRO_0000163031.
FT   NP_BIND      90     91       NADPH. {ECO:0000250}.
FT   NP_BIND     258    259       NADPH. {ECO:0000250}.
FT   REGION       88     90       Substrate binding. {ECO:0000305}.
FT   REGION      229    230       Substrate binding. {ECO:0000305}.
FT   ACT_SITE    190    190       Thioimide intermediate.
FT                                {ECO:0000305|PubMed:23595998}.
FT   ACT_SITE    197    197       Proton donor.
FT                                {ECO:0000305|PubMed:23595998}.
FT   MUTAGEN      89     89       E->A,L: Drastic decrease in activity.
FT                                {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN      90     90       S->A: 9-fold decrease in specific
FT                                activity. {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN     190    190       C->A: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN     197    197       D->N: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN     228    228       F->W: 11-fold decrease in specific
FT                                activity. {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN     229    229       H->A: 6.5-fold decrease in specific
FT                                activity. {ECO:0000269|PubMed:23595998}.
FT   MUTAGEN     230    230       E->Q: 26-fold decrease in specific
FT                                activity. {ECO:0000269|PubMed:23595998}.
SQ   SEQUENCE   282 AA;  32588 MW;  3C22B9BA7AA3C79D CRC64;
     MSSYANHQAL AGLTLGKSTD YRDTYDASLL QGVPRSLNRD PLGLKADNLP FHGTDIWTLY
     ELSWLNAKGL PQVAVGHVEL DYTSVNLIES KSFKLYLNSF NQTRFNNWDE VRQTLERDLS
     TCAQGKISVA LYRLDELEGQ PIGHFNGTCI DDQDITIDNY EFTTDYLENA TCGEKVVEET
     LVSHLLKSNC LITHQPDWGS LQIQYRGRQI DREKLLRYLV SFRHHNEFHE QCVERIFNDL
     LRFCQPEKLS VYARYTRRGG LDINPWRSNS DFVPSTTRLV RQ
//
